See more : Guandao Puer Investment Co., Ltd S.A. (MLGDI.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Quantum-Si incorporated (QSI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Quantum-Si incorporated, a leading company in the Biotechnology industry within the Healthcare sector.
- Ecofin U.S. Renewables Infrastructure Trust PLC (RNEW.L) Income Statement Analysis – Financial Results
- Argent Minerals Limited (ARD.AX) Income Statement Analysis – Financial Results
- TAI-TECH Advanced Electronics Co., Ltd. (3357.TWO) Income Statement Analysis – Financial Results
- Iovance Biotherapeutics, Inc. (IOVA) Income Statement Analysis – Financial Results
- Aura Renewable Acquisitions plc (ARA.L) Income Statement Analysis – Financial Results
Quantum-Si incorporated (QSI)
About Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 1.08M | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 594.00K | 2.58M | 1.04M | 894.00K | 0.00 |
Gross Profit | 488.00K | -2.58M | -1.04M | -894.00K | 0.00 |
Gross Profit Ratio | 45.10% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 67.03M | 72.06M | 46.58M | 27.56M | 28.10M |
General & Administrative | 42.81M | 42.29M | 46.38M | 7.98M | 7.88M |
Selling & Marketing | 400.00K | 7.00K | 3.96M | 1.15M | 634.00K |
SG&A | 44.63M | 42.30M | 50.33M | 9.14M | 8.52M |
Other Expenses | 0.00 | -20.15M | -5.00M | -10.00K | 5.00K |
Operating Expenses | 111.66M | 114.36M | 96.91M | 36.69M | 36.62M |
Cost & Expenses | 112.25M | 114.36M | 96.91M | 36.69M | 36.62M |
Interest Income | 0.00 | 0.00 | 2.54M | 88.00K | 823.00K |
Interest Expense | 0.00 | 0.00 | 5.00K | 9.00K | 0.00 |
Depreciation & Amortization | 4.16M | 2.58M | 1.04M | 894.00K | 780.00K |
EBITDA | -91.80M | -129.86M | -95.87M | -35.80M | -35.84M |
EBITDA Ratio | -8,484.66% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -111.17M | -123.84M | -96.91M | -36.69M | -36.62M |
Operating Income Ratio | -10,274.58% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 15.21M | -8.60M | 1.92M | 78.00K | 828.00K |
Income Before Tax | -95.96M | -132.44M | -94.99M | -36.61M | -35.79M |
Income Before Tax Ratio | -8,868.76% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 8.60M | -6.04M | -1.00K | 5.00K |
Net Income | -95.96M | -141.04M | -88.95M | -36.61M | -35.80M |
Net Income Ratio | -8,868.76% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.68 | -1.01 | -1.12 | -6.81 | -0.26 |
EPS Diluted | -0.68 | -1.01 | -1.12 | -6.81 | -0.26 |
Weighted Avg Shares Out | 141.30M | 139.26M | 79.58M | 5.38M | 136.40M |
Weighted Avg Shares Out (Dil) | 141.30M | 139.26M | 79.58M | 5.38M | 136.40M |
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar
Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform
Quantum-Si: Commercial Lift Imminent
Quantum-Si Introduces World's First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
Quantum-Si Expands Global Reach with Addition of New Distributor
Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows
Quantum-Si Incorporated (QSI) Q3 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports